Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
MEDGENOME Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Our powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare. MedGenome Inc. has its Corporate Headquarters and a Next Generation Sequencing (NGS) lab in Foster City, California, US. MedGenome Labs is … Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology | 6 | 3 | 3 | 874 | |
H3 Biomedicine Human. Health. Hope. H3 Biomedicine is a privately held biopharmaceutical company focused on the discovery and early development of novel, targeted anti-cancer compounds for the unmet needs of genetically defined patient populations. H3 has leveraged its integrated expertise in genomics, tumor biology, bioinformatics and innovative synthetic organic chemistry to create an integrated drug development ecosystem to deliver patient-based, genomics-driven, small molecule drugs. In less than three years, H3 has developed four discovery platforms, which have produced two drug candidates for which the company expects to file investigational new drug (IND) applications in late 2015. Founded by a $200 million dollar … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 0 | 2 | 38 | |
FULFIL FULFIL bars are packed with protein, have less than 3g of sugar, 9 vitamins and taste unreal! #LifesWonderfuel FULFIL bars are packed with protein, 9 vitamins, have less than 3g of sugar and taste amazing! Talk about feeding the dream #LifesWonderfuel Type: Startup Activities: foodtech Technologies: Synthetic Biology | 4 | 0 | 1 | 17 | |
Medical Optometry America MOA helps preserve the beauty of sight by expanding access to high-quality medical eye care. Medical Optometry America (MOA) helps preserve the beauty of sight by expanding access to high-quality medical eye care. Our medical optometrists have received extensive additional training and are committed to excellence in visual and ocular health. Their experience, supported by the advanced technology available at the MOA Diagnostic and Therapeutic Center, enables them to provide exceptional patient outcomes. With Medical Optometry America, you get the best of today’s leading medical science with personalized care from our primary eye care doctors. Medical Optometry, Medical Eye Care, … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 16 | |
Sensing Future Technologies a greater step Welcome to Sensing Future Technologies! We are manufacturers of technological medical devices for the global market. We produce: - Force and pressure platforms for balance assessment and training; - Active and passive robotic systems; - We develop our own software. We raise the standards of physical and vestibular rehabilitation thinking about all those who suffer from balance disorders. We are certified by ISO 9001 and ISO 13485 standards for medical devices. Dispositivos Médicos, Telemedicina, Robótica, Robótica Médica, Inovação, Fisioterapia, Reabilitação, Hardware, Software, Medical Devices, Telemedicine, Robotics, Medical Robotics, Inovation, Physiotherapy, Rehabilitation, vestibular rehabilitation, and pressure sensors Type: Startup Activities: healthtech deeptech Technologies: Robotics Synthetic Biology | 0 | 0 | 0 | 9 | |
Numalogics Insight into the biomechanics of human-device interaction Numalogics virtual lab provides insight into the biomechanics of human-device interaction. Simulation, Biomechanics, sportsgear, and medical devices Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 10 | |
Medicenna Therapeutics Corp. Evolutionary Cytokines | Revolutionary Medicines | TSX: MDNA | OTCQB: MDNAF Medicenna is a clinical stage immunotherapy company focused on the development of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Superkines. Medicenna's long-acting IL-2 Superkine, MDNA11, is a next-generation IL-2 with superior CD122 binding without CD25 affinity thereby preferentially stimulating cancer killing effector T cells and NK cells. Medicenna’s early-stage BiSKITsTM program, (Bifunctional SuperKine ImmunoTherapies) is designed to enhance the ability of Superkines to treat immunologically “cold” tumors. Medicenna's IL-4 Empowered Superkine, MDNA55, has been studied in 5 clinical trials including a … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 0 | 25 | |
mimiX Biotherapeutics Next Generation Biofabrication - Sound Induced Morphogenesis //Acoustic biofabrication MimiX biotherapeutics introduces Sound Induced Morphogenesis. We extend the boundaries of biofabrication, making bioengineered, artificial human organs and tissues a future reality. Sound Induced Morphogenesis (SIM) is a revolutionary approach in biofabrication. It mirrors nature’s design, to aggregate and pattern biologicals by tuning sound profiles under contactless, fast and delicate culture conditions resulting in a morphologically induced tissue generation. We introduce cymatiX®, a unique acoustic biofabrication solution that makes the Sound Induced Morphogenesis technology easily accessible to the scientific and clinical community Visit www.mimixbio.com to learn more. mimiX biotherapeutics is a … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 5 | 1 | 0 | 7 | |
Genomic Expression Inc The RNA Platform - by analyzing RNA we can detect disease, monitor health and design the Next Generation Cures Today only 1 out if 4 cancer drugs prolongs life because we treat all the patients the same way. Genomic Expression’s OneRNATM test can save lives and make healthcare delivery more effective by sequencing RNA and linking RNA’s to approved therapies and clinical trials. Genomics, information, personalized medicine, personalized diagnostics, Sequencing, prognostics, bioinformatics, sample preparation, Next Generation Sequencing, Biobank, Access to biological samples, target filtering, RNA-seq, RNA sequencing, and RNASeq of FFPE samples Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 12 | |
ReHand The new tool of hand, wrist, and fingers rehabilitation through a tablet device ReHand is a hand rehabilitation app that qualifies as a Class I medical device. hand therapy, terapia de mano, telerehabitation, and telerehabilitación Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 0 | 0 | N/A | |
Flybox® Insect Waste Management SolutionsTM Founded in 2021, Flybox® builds and support modular insect farms that turn the waste we already have into food supply we dearly need. Leading edge food & organic waste businesses deploy Flybox® technology on-site to upcycle organic waste into insect protein and fertiliser, to use or sell. With bases in the UK and Kenya, Flybox® technology enables global adoption of insect-farming technology for a wide range of use cases. Flybox® is the future of sustainable food production, today. insect farming, black soldier fly, Agritech, African startup, Insect technology, and black soldier fly technology Type: Startup Activities: foodtech Technologies: Synthetic Biology | 2 | 0 | 2 | 28 | |
OncoLize "Treating Tumors from the Inside" - Intra-tumoral delivery of oncology drugs OncoLize (NL) develops intra-tumoral drug depots to "Treat Tumors from the Inside". This means clinicians can inject and keep certain drugs where they are most effective: inside the tumor mass. Our patent protected ChemoGell(TM) platform is based on hydrogel technology, an awesome injectable drug depot platform developed at RCSI, Dublin by prof.dr. Helena Kelly and her team. We have an exclusive, world wide license for oncology. The base-patents have recently been granted in US, EU, China and Japan, with more in the pipeline. With the Gastro-Oncology team at Leiden … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 5 | |
OSSTEC Bone healing orthopaedics to keep patients healthy and active | Currently seeking investment | We're hiring! Osteoarthritis causes chronic pain for 33% of the population and is treated with joint replacement. 1.3M knee replacements are performed globally every year - 450,000 of them are in young patients with high risk of failure and revision surgery. These patients experience poorer outcomes so surgeons are reluctant to treat them. OSSTEC has developed an additive manufacturing bone healing technology, currently applied in partial knee implants. Our implants stimulate long-term bone growth to resolve common sources of failure: loosening and bone loss. Our vision … Type: Startup Activities: it services Technologies: Synthetic Biology | 1 | 0 | 1 | 12 | |
Daytot Where remarkable journeys start Daytot is an innovative early intervention brand, developing life-enhancing products aimed at improving the developmental outcomes for babies with delayed development. We are a company with heart, using innovation and research to create and introduce developmental products into a baby's daily routine from day one. Working with the best minds in the world, we collaborate through research & design, to unlock new insights and create groundbreaking products, to support babies in achieving milestones with comfort and purpose. Our therapist-approved products are uniquely designed for hospital and home use. Working closely with neonatal and paediatric therapists, we … Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 2 | |
Cube Biotech The native drug discovery enablers for complex targets. Let's pioneer together! Cube Biotech is a contract research organization of membrane protein scientists offering non-GMP services for many applications. We assist in protein preparation, biophysical target characterization, and structure determination by cryo-EM or assay development. Our USP is a vast synthetic copolymer portfolio, enabling more reliable membrane protein research. Copolymers offer, in contrast to detergents, a broad and native picture of your target. Discover endless customization possibilities with our Protein Services – your project, your way, as easy as building with Lego bricks! Build frameworks that are easily incorporated into your … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 40 | |
Anaconda BioMed NEXT GENERATION OF CATHETERS Health is the level of functional or metabolic efficiency of a living organism. In humans it is the ability of individuals or communities to adapt and self-manage when facing physical, mental or social challenges. Health, medical devices, stroke, and thrombectomy Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 0 | 0 | 33 | |
Tetrahedron SAS The goal of Tetrahedron is to help maintain or restore a healthy life by designing and developing new active ingredients for cosmeceutical, nutritional, biomedical and therapeutical applications. These ingredients may be natural compounds, for which Tetrahedron develops new and sustainable synthesis processes allowing an industrial production of these compounds, or novel molecules derived from natural compounds, therefore providing proprietary compounds. Oxidative stress, Free radical biology, Antioxidant, Sulfur and selenium chemistry, Process development, Ergothioneine, Green chemistry, Sustainable chemistry, and Rare sulfur-containing amino acids Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 3 | |
HOMEPERF [Automatic translation follows] Care partner in home treatments Homeperf is a major player in home care. Since its creation in 1997, Homeperf has been invested in improving patient care to provide better care. Better care for patients, their loved ones, the health system and the environment, an issue that is now closely linked to health. By joining the SAPIO group, an international group, we have strengthened our desire to participate in this improvement in the quality of care. Committed to healthcare professionals, whether hospital or private, Homeperf guarantees continuity of care. We work with patients receiving infusions, treated for chronic … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 364 | |
LSO Medical [Automatic translation follows] Constantly serving patients through medical innovation Founded in 2002, LSO Medical is a French company based in Loos, a pioneer and expert in thermal endovenous treatment. With more than 20 years of experience, LSO Medical is a key player in the design, production and marketing of medical lasers. LSO Medical is ISO 13485 certified for its medical device design and manufacturing activities. With this experience, LSO Medical now supports its French and international customers in the implementation of equipment, such as the ENDOTHERME 1470 Laser and Ringlight fiber consumables for thermal ablation of varicose veins; the EXOTHERME … Type: SMB Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 43 | |
ALYATEC Research and Expertise in Environmental Diseases ALYATEC is a CRO and clinical trial center conducting clinical trials related to allergic and respiratory diseases. We evaluate the efficacy and safety of all kind of solutions intended for allergic asthma, rhinitis, conjunctivitis, atopic dermatitis, rhinosinusitis, severe asthma and food allergy: drugs, medical devices, air purifiers, dietary supplements, face masks, homeopathy ... We have a large database of patients and a network of local physicians offering high patients' recruitment capabilities and deep expertise in clinical data collection as an investigational site. We can also use this database to conduct real-world studies (RWE/RWD). In … Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 10 | |
Urosphere Your partner in uro-genital pre-clinical research UROSPHERE is a leading Contract Research Organization specializing in preclinical urogenital, gastro-intestinal and oncological pharmacology studies. We provide the pharmaceutical and biopharmaceutical industries with a unique experimental research platform combining both in vivo models and in vitro assays on human and animal tissues. Innovation, Uro-genital pathologies, Oncology, PDX models, Organoids, CRO, Preclinical Research, Pharmacology, Drug development, Gastrointestinal pathologies, Experimental models, Pain, and Inflammation Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 0 | 1 | 18 | |
Genourob - Medical Device Manufacturer French Knee & Spine medical device manufacturer. We create the new boundaries of orthopaedic care every day! Based in France, Genourob is the leader in designing, producing and marketing of medical devices for the evaluation of the state and performance of the ligamentous structures of the knee. Furthermore, we also developed a revolutionising rehabilitation device to prevent & treat back pathologies through strengthening & mobilisation of the deep core muscles around the spine. Genourob distinguishes itself from other companies through its innovation and determination to live in a world where Anterior Cruciate ligament (ACL) injuries are effectively diagnosed and taken … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 8 | 0 | 0 | 19 | |
SIFI Since 1935 always committed to improve patients’ quality of vision. SIFI is expanding into international market providing innovative solutions for ocular diseases. Eye Care, Pharmaceutical/Nutraceuticals/Medical Devices, Surgical & Diagnostic Medical Devices., Ophthalmology , Science, Researchers , Research, Vision, Eyes, Surgical, Medical technology, Health, Medicine , Eye health , and Biotech Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 2 | 0 | 0 | 584 | |
Cynata Therapeutics A Next Generation Stem Cell Therapeutics Company Cynata Therapeutics Limited (ASX: CYP) is an Australian clinical-stage stem cell and regenerative medicine company focused on the development of therapies based on CymerusTM, a proprietary therapeutic stem cell platform technology. CymerusTM overcomes the challenges of other production methods by using induced pluripotent stem cells (iPSCs) and a precursor cell known as mesenchymoangioblast (MCA) to achieve economic manufacture of cell therapy products, including mesenchymal stem cells (MSCs), at commercial scale without the limitation of multiple donors. Cynata’s lead product candidate CYP-001 met all clinical endpoints and demonstrated positive safety and efficacy data for … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 1 | 0 | 11 | |
Bactiguard AB Bactiguard is a global innovative medtech company with Swedish roots and a purpose to prevent infections. Bactiguard is a global MedTech company developing safe and biocompatible technology to prevent medical device related infections. The company’s unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard’s infection prevention technology and solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine. Bactiguard operates through license partnerships with leading global MedTech companies that apply … Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 5 | 0 | 2 | 97 | |
Cleara Biotech B.V. Targeting cellular senescence to extend human healthspan at old age and to counteract late stage cancer Cleara is a biopharmaceutical R&D company dedicated to discovery and development of therapies against cancer and chronic diseases through selective elimination of subtypes of cellular senescence. Through detailed understanding of the molecular and biological pathways that underlie these individual pathological phenotypes, we set up disruptive, innovative and proprietary platform technology to design and optimize (peptide-based) therapeutics that exploit their weak spots for safe and selective clearance. Cleara’s lead FOXO4 program is focused on generation of disruptive and proprietary technology against “scarred” cellular senescence for … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 15 | |
Cast21 Elevating the way the world heals through our waterproof cast and brace alternatives for the 21 Century. Cast21 is a medical device company that creates innovative healthcare solutions, inspiring change in the way the world heals. Our first product offers a waterproof alternative to casting or bracing for the treatment of bone fractures or joint injuries. This alternative improves the quality of life of patients through its breathable and lightweight design. Doctors benefit from a streamlined application and removal process that does not require any scanning or sawing equipment, heat, water, or electricity. We are registered and listed with the … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 4 | 0 | 3 | 13 | |
Physiogenex Leading preclinical CRO specializing in metabolic disorders. Physiogenex is a leading preclinical research organization (CRO) specializing in metabolic disorders such as diabetes, insulin resistance, obesity, fatty liver (NASH / NAFLD), dyslipidemia, atherosclerosis and cardiovascular complications. We provide: - Classical and proprietary diet-induced in vivo models - Innovative in-house techniques (RCT) and gold standard methods (glucose clamps with radiolabelled tracers, ...) - In vivo preclinical imaging services Our models and technologies are customized and we deliver unparalleled scientific expertise for R&D, preclinical development, post-marketing studies and drug repositioning. We provide both the biopharmaceutical and nutraceutical companies with optimal and reliable solutions … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 2 | 21 | |
Fresenius Kabi France [Automatic translation follows] Fresenius Kabi is a global healthcare company specializing in life-saving medicines and medical devices in infusion, transfusion and clinical nutrition. Fresenius Kabi’s medicines, technologies and services are used to help care for patients in emergency situations and with chronic diseases. Fresenius Kabi’s product portfolio includes a comprehensive range of generic intravenous medicines, infusion therapies, clinical nutrition products and the medical devices needed to deliver these products. In the area of biosimilars, we focus on autoimmune diseases and oncology. In 2019, Fresenius Kabi’s first biosimilar product was launched. In the area of transfusion medicine and cell therapies, Fresenius … Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 15 | 1 | 11 | 452 | |
Sonoscanner - Premium Ultrasound Scanners [Automatic translation follows] Premium Diagnostic Ultrasound ➡ Are you a doctor or health practitioner? ➡ Do you practice ultrasound or do you want to integrate ultrasound into your daily practice? Benefit from Sonoscanner ultrasound scanners, made in France! At Sonoscanner, a French manufacturer of ultrasound scanners, we believe that every doctor deserves the best in innovation and support to establish accurate diagnoses while enjoying their practice. More than 4,400 doctors practice ultrasound daily thanks to Sonoscanner. Our range is based on 3 models of ultrasound scanners, to perfectly fit your needs. ✅ Portable ✅ Ultra-portable ✅ Stationary Our ultrasound scanners … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 4 | 2 | 3 | 32 | |
Texcell Expert in viral safety since 1987. Texcell is a dedicated partner for biotechnology and pharmaceutical companies since more than 2 decades. Thanks to an unique combination of expertise in Virology and Immunology, we can provide a full support to your product development from the proof of concept to clinical studies and GMP manufacturing. Our state-of the Art facilities are located in France, Germany and in the US where we use most recent technologies to efficiently perform a wide range of assays What do we provide ? A specialized analytical lab for your preclinical and clinical studies, including: - Cell based … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 1 | 7 | 107 | |
insitro Making medicines differently to bring better drugs faster to the patients who benefit most with ML and data at scale. insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients. At insitro, we are rethinking the entire drug discovery process, from the perspective of machine learning, human genetics, and high-throughput, quantitative biology. Over the past five decades, we have seen the development of new medicines becoming increasingly more difficult and expensive, leaving many patients with significant unmet need. We’re embarking on a new approach … Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 21 | 1 | 17 | 327 | |
oncgnostics GmbH Precision in Cancer Diagnostics oncgnostics develops – based on proprietary epigenetic biomarkers - highly reliable molecular in vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. Diagnostik, Epigenetik, Medizin, Assay Development, Diagnostics, DNA-Methylation, Medicine, and LifeScience Developments Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 25 | |
MarraBio Building Better Biology At MarraBio we design, engineer and construct bacterial protein polymers, that contain the biological messages that cells need to grow, divide and behave properly. Cells grown on an industrial scale for research, agricultural or therapeutic use need to be supplied with the right signals. We provide a multi-functional, cost effective solution in a single, easy to use material. Find out more at https://www.marrabio.com/ Protein Engineering, Protein Production, Cellular Agriculture, Cultivated Meat, Research Reagents, Stem Cell Expansion, and Industrial Scale Cell Culture Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 9 | |
Pencil Biosciences Limited Developing the Next Generation Gene Editing Technology Pencil Biosciences is developing a truly innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. Genome Engineering, Research and Development, and Gene Editing Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 15 | |
Nanobots Therapeutics Therapeutics In-Motion A Biomedical Company Improving Drug Accumulation In Cancer Cells Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 7 | |
Neurosterix a biopharmaceutical company focused on developing allosteric modulators for the treatment of neurological disorders Neurosterix is a biopharmaceutical company focused on developing allosteric modulators for the treatment of neurological disorders. Our drug discovery and development platform identifies and develops allosteric modulators — molecules that increase or decrease the activity of target receptors by binding outside of the “active site” where endogenous ligands and traditional drugs operate. Through this platform, Neurosterix’s novel drug candidates have the potential to provide medicines with improved efficacy, safety and tolerability for patient communities suffering from underserved neurological disorders. Type: Startup Activities: legaltech Technologies: Synthetic Biology | 1 | 1 | 0 | 18 | |
Akthelia Pharmaceuticals Modulating innate immunity to improve cancer therapy outcomes. . Akthelia Pharma is a late preclinical-stage immunotherapy company, with its HQ in Iceland, targeting a huge unmet opportunity to improve cancer and cell/organ transplant outcomes through reducing the risk of neutropenic sepsis. This potentially fatal complication of systemic anticancer treatment, where a combination of reduced neutrophil count and loss of GI integrity results in bacteremia from the patient's own microbiome, is the leading cause of death associated with chemotherapy (up to 20% mortality) -- other than disease progression. Our breakthrough patented strategy, which is supported by world-leading KOLs, is to specifically … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 4 | |
KT Tape Providing healthy solutions to the active consumer to prepare, perform, and recover. KT was founded in Utah in 2008 to provide breakthrough, drug-free solutions to athletes with its top tier kinesiology tape. Since then, we've become the market leader in our category in the US and now distribute our tape and other products globally. Our purpose is to empower movement to unleash every body's potential. As part of the KT team, you will help further our vision to become the leader in healthy solutions for active consumers to prepare, perform and recover for the activities they are passionate about. Purpose: … Type: Startup Activities: sporttech consumer goods Technologies: Synthetic Biology | 8 | 2 | 2 | 74 | |
IntuiTap Medical, Inc. At IntuiTap Medical, we are eliminating the guesswork, frustration, and pain from spinal punctures—procedures that are wrought with inaccuracy and inefficiencies. Our handheld, easy-to-use device is the world's first comprehensive solution that enables accurate spinal-needle placements for lumbar punctures, spinal anesthesia, epidurals, and drug delivery. Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 1 | 1 | 8 | |
Quince Therapeutics Dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases Quince Therapeutics, Inc. is a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases. Our Phase 3 lead asset, EryDex, is the first product in development that leverages our proprietary Autologous Intracellular Drug Encapsulation, or AIDE, technology platform, which is a novel drug/device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. Red blood cells have several characteristics that make them a potentially effective vehicle … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 2 | 1 | 26 | |
IMMvention Therapeutix, Inc. Interventions for Human Diseases Venture-funded company, discovering and developing oral novel small molecule first-in-class inhibitors of Bach1 (a transcription factor) as transformative potential therapy, globally accessible for patients with sickle cell disease (SCD), renal, cardiometabolic and neurodegenerative and other diseases. Sickle Cell Disease, fetal hemoglobin induction, beta-thalassemia, Renal diseases, cardiometabolic diseases, and neurodegenerative diseases Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 10 | |
Intensity Therapeutics, Inc. A clinical stage biotechnology company whose mission is to create safer and more efficacious cancer therapies. Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 1 | 2 | 13 | |
Magenta Therapeutics Developing novel medicines to bring the curative power of stem cell transplants to more patients Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients. Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com. Follow Magenta on Twitter: @magentatx. Hematopoietic Stem Cell … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 2 | 1 | 68 | |
Arcturus Therapeutics A global mRNA medicines and vaccines company Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a global mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR® mRNA Technology (sa-mRNA) and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus developed Kostaive®, the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine in the world to be approved. Arcturus has an ongoing global collaboration for innovative mRNA vaccines with CSL Seqirus, and a joint venture in Japan, ARCALIS, focused on the manufacture of mRNA vaccines and therapeutics. Arcturus’ … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 1 | 2 | 204 | |
Casebia Therapeutics An innovative gene editing company discovering and developing curative treatments for genetic diseases Bayer and CRISPR Therapeutics have entered into an agreement to create Casebia to discover, develop and commercialize new breakthrough therapeutics to cure blood disorders, blindness, and congenital heart disease. CRISPR Therapeutics will contribute its proprietary CRISPR-Cas9 gene-editing technology and intellectual property, while Bayer will make available its protein engineering expertise and relevant disease know-how. It is the first long-term strategic partnership of its kind to make a substantial investment in the development of target delivery systems in an effort to bring systemic in vivo CRISPR-Cas9 gene editing … Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
Knip Our mission: Save (fish) lives, improve farm profitability, and contribute to a food-secure future. We are Knip (formally KnipBio), a women-led biotechnology company based in Boston, pioneering advanced nutritional solutions for animal feeds. Using a naturally occurring microbe, our precision feed ingredients are sustainably produced without reliance on arable land and minimal water use. aquaculture, agriculture, synthetic Biology, fermentation, and blue economy Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 3 | 4 | |
Sana Health Relief made possible. Sana guides users into a deep state of relaxation, accelerating physical and mental recovery. Sana is a digital heath company driven by 25 years of research into relief for symptoms of chronic pain and insomnia. Sana is developing the first non-invasive, comfortable bio-therapeutic device capable of inducing a deep restorative state of relaxation to alleviate pain and tension. The device provides relief in just 10 minutes through the use of audio-visual neuromodulation, and is currently undergoing FDA certification and clinical trials. Chronic Nerve Pain, Chronic Pain, PTSD, Post Traumatic Stress Disorder, Stress, Anxiety, Sleep, Medical Devices, and … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 5 | 1 | 2 | 23 | |
RevBio, Inc. Transforming Bone Repair RevBio was started with one goal in mind—to end medicine’s 50 year search for a biocompatible bone adhesive. Effective for bone-to-bone as well as bone-to-metal wet field applications, Tetranite® is a revolutionary biomaterial that promises to transform bone repair—for both patients and clinicians. Inspired by the marine animal the sandcastle worm, Tetranite is simple chemistry. Bioengineered from the worm’s secreted protein, our synthetic adhesive is the only patented biomaterial which satisfies both the required and desired properties for a bone adhesive: wet field performance, multi-surface bonding, rapid mechanical stability, and controlled biodegradability. The properties of TetraniteTM include … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 0 | 2 | 31 | |
Molecular Templates Engineering the Next Generation of Therapeutics Molecular Templates, Inc. (MTEM) is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform with unique mechanisms of actions which are highly differentiated from antibody drug conjugates (ADCs). MTEM is developing MT-6402, which is in a Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients; MT-5111, which is in a Phase I clinical trial for the treatment of HER2-positive cancers; and MT-0169, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 55 | |
Blueprint Medicines Striving to improve and extend patients' lives Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 1 | 6 | 729 | |
C4 Therapeutics, Inc. Clinical-stage biotech company transforming how disease is treated through targeted protein degradation science C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 3 | 5 | 123 | |
Disease Diagnostic Group, Inc Disease Diagnostic Group, Inc is focused on screening, tracking, and diagnosing highly infectious or neglected tropical diseases through portable and reusable devices. Medical Device Design, Malaria, Infectious Disease, and Diagnostics Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 2 | 1 | 0 | 1 | |
Fisher Wallace Laboratories, Inc. Better tech for mental health. Fisher Wallace Labs is on a mission to vastly increase access to mental healthcare. We develop and commercialize wearable brain stimulation technology for the treatment of depression, anxiety, and other neuropsychiatric and cognitive disorders. Our technology was recently proven to be rapidly effective in two large clinical trials for the treatment of Major Depressive Disorder and Generalized Anxiety Disorder, the latter of which was conducted in collaboration with the Seattle Police Department and Washington State University. Previous research includes a successful pilot study conducted at Beth Israel Hospital for the treatment of Bipolar II Depression, … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 11 | |
Akili Welcome to Akili! At Akili, we believe there is potential for medicine to be developed, delivered and experienced in a completely different way. We’re bringing together world-class neuroscience with exceptional creativity and video game development to challenge the status quo of medicine. Our digital medicine is not delivered through a pill, but rather through a patented and captivating video game experience. Effective medicine that’s captivating and enjoyable to use – now that’s refreshing! We're continuously evaluating new technologies and are advancing a broad pipeline of programs to treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 2 | 8 | 133 | |
FIECON Great Place To Work®. We're committed to making a positive difference in the lives of our people, clients, and society. FIECON was born out of the desire to make a difference in the world we live in – harnessing the power of health economics for the good of humanity. To date, we have donated over £900,000 to charitable causes. Our services: We provide services across the life cycle of a product and have worked in countries across the globe. Our key service areas comprise: • Outcomes Research • Economic Modelling • Health Technology Assessment • Value Communication • Pricing & … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 113 | |
GENOSKIN First-in-human data to accelerate drug development Genoskin is a pioneering contract research organization that leverages ethically sourced human skin to accelerate the development of biotherapies, vaccines, medical devices, and cosmetics. By integrating advanced technologies like transcriptomics, spatial biology, and bioinformatics with our ex vivo human skin models, we offer a robust platform for predicting compound efficacy and safety before human trials. Our models provide unparalleled insights into substance interactions, absorption, irritation, and overall skin response, reducing time-to-market and minimizing development risks. Committed to ethical research, we replace animal testing with human-relevant data, driving innovation in the biomedical, cosmetics, and skincare … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 18 | 6 | 10 | 45 | |
ReviveMed AI-based Metabolic Platform for Precision Medicine ReviveMed, an MIT spinout, develops an AI-based metabolomic platform and digital metabolic twins to simulate disease progression and treatment response. We advance genomics by leveraging crucial yet underexplored metabolite data, e.g., glucose or cholesterol, as our patented AI technology can characterize 20 times more metabolites and pioneer pre-trained generative models for metabolomics. We have growing precision medicine programs for oncology and cardio-metabolic diseases. In oncology, we have identified metabolic mechanisms regulating immune activity and a blood-based test of immune checkpoint inhibitor (ICI) response, addressing limited efficacy (<25% benefit), validated in renal cell carcinoma, where … Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 3 | 3 | 1 | 5 | |
Orig3n COVID-19 testing, Wellness DNA Testing, Personalized Vitamins, and Regenerative Medicine Orig3n received Emergency Use Authorization clearance for their COVID-19 test on April 10, 2020. In addition to continuing work to provide the world with more knowledge about themselves based on their DNA, Orig3n is providing much needed COVID-19 capacity to nursing homes, boarding schools, clinicians, and underserved communities across the country. Orig3n helps people understand the links between their genes and how their minds and bodies work. From fitness to nutrition to personality, our DNA tests provide easy, affordable access to genetic information and guidance on how to use it. … Type: Startup Activities: biotech healthtech deeptech Technologies: Synthetic Biology | 11 | 1 | 10 | 11 | |
NGM Biopharmaceuticals Explorers on the frontier of life-changing science. NGM Bio is a biopharmaceutical company focused on discovering and developing novel, life-changing medicines for people whose health and lives have been disrupted by disease. The company’s biology-centric drug discovery approach aims to seamlessly integrate interrogation of complex disease-associated biology and protein engineering expertise to unlock proprietary insights that are leveraged to generate promising product candidates and enable their rapid advancement into proof-of-concept studies. As explorers on the frontier of life-changing science, NGM Bio aspires to operate one of the most productive research and development engines in the biopharmaceutical industry. All therapeutic candidates … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 2 | 1 | 2 | 158 | |
Aker BioMarine ASA Aker BioMarine is a leading global innovator that develops krill-derived products for consumer health and nutrition Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. We bring our nutrient-rich, all-natural krill ingredient to the pharmaceutical and nutraceutical markets through our leading brands: Superba Krill Oil, Lysoveta, Understory, and Kori Krill. Our innovative approach also extends into our spin-offs FloraMarine (plant-based source of omega-3 from algae), AION (reduce and recycle plastic waste across industries), and Understory (our protein brand). The brand results from our belief that krill is an ancient natural … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 9 | 1 | 7 | 335 | |
Biomecanica [Automatic translation follows] Orthopedic implant and prosthesis industry with over 36 years of HISTORY, TRUST AND TRANSPARENCY. Founded in 1988, Biomecanica is headquartered in Jaú, in the interior of São Paulo, with one of the most advanced industrial parks in Latin America. Biomecanica has 120 employees, 1,000 products in production, 5,000 sub-items in production, not counting the products in the Stars line. Biomecanica invests in state-of-the-art machining equipment, in addition to having a laboratory in its infrastructure, with ISO 7 and ISO 5 quality certifications (aseptic mode) provided by ANVISA itself, for the production of biomaterials. With the partnership of … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 181 | |
SMICES SURGICAL You take care of others, we take care of you. SMICES is a european company based in Montpellier, which offers innovative, smart, and effective solutions, to the challenges encountered in the medical and surgical field. SMICESs commitment: improve the well-being of surgical teams and the safety in the operating theatre, in order to provide better patient care. SMICES works side by side with surgeons to develop the best medical devices, suitable for use in the operating room. For some years, the problem of the surgical smoke hazards during laparoscopy is raised. These smokes contain harmful substances and cause visual and … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 5 | 2 | 1 | 2 | |
AXIENCE S.A.S. [Automatic translation follows] Axience was created in 2001 and became a veterinary pharmaceutical operator in 2005. Portfolio of drugs, originators and generics, intended for pets, horses, cattle and pigs Very strong specialization in hygiene and disinfection of veterinary clinics since 2003 and in anesthesia and analgesia for all species since 2009. Anesthesia, Disinfection, Veterinary Biocides, and Analgesia Type: SMB Activities: foodtech Technologies: Synthetic Biology | 0 | 0 | 0 | 45 | |
Theraclion Creators of extracorporeal robotic treatment platforms Theraclion is a French MedTech company committed to developing a non-invasive alternative to surgery through the innovative use of focused ultrasound. High Intensity Focused Ultrasound (HIFU) does not require incisions nor an operating room, leaves no scars, and allows patients an immediate return to their daily activities. Echotherapy, as the HIFU treatment method is called, concentrates therapeutic ultrasounds to an internal focal point from outside of the body. Theraclion has developed two CE-marked robotic platforms delivering echotherapy: SONOVEIN® for varicose veins and ECHOPULSE® for breast fibroadenoma and thyroid nodules. Each representing the potential to … Type: SMB Activities: healthtech deeptech Technologies: Robotics Synthetic Biology | 2 | 0 | 2 | 35 | |
PHAXIAM Therapeutics Creating a global leader in extended phage therapies PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. PHAXIAM is listed on the Nasdaq Capital Market in the United States (ticker: PHXM) and on the Euronext regulated market in Paris … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 15 | 5 | 8 | 84 | |
Innate Pharma Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need. Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 21 | 9 | 14 | 195 | |
AgeX Therapeutics, Inc. AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targeting human aging. AgeX Therapeutics, Inc. (“AgeX”) is a biotechnology company focused on the emerging field of interventional gerontology. Its technology platform is built upon a modern understanding of the molecular basis of cellular immortality and regenerative biology. Leveraging technology licensed from parent company BioTime, Inc. as well as Geron Corporation, AgeX is leading the development of novel therapeutics targeting some of the largest market opportunities associated with an aging population. Type: Startup Activities: deeptech biotech silvertech Technologies: Synthetic Biology | 0 | 0 | 0 | 12 | |
UNITY Biotechnology UNITY is harnessing pathways of aging biology to develop new medicines, with a focus on retinal diseases. As pioneers in cellular senescence, UNITY is advancing the first senolytic therapeutic candidate for retinal diseases that aims to restore diseased tissue to a healthier state, a potentially paradigm shifting treatment in ophthalmology. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 | 1 | 32 | |
BrainXchange Your source for all things XR, digital twins, AI, and emerging tech in enterprise BrainXchange is a world-class conference organizer and thought leader in the enterprise AR/VR/MR (XR), digital twins, AI, and related emerging enterprise technology space. B2B Events, Augmented Reality, Virtual Reality, Tech Expo, Mixed Reality, Exoskeletons, Internet of Things (IoT), Enterprise Mobility, Emerging Technology, Metaverse, Spatial Computing, Digital Twins, Artificial Intelligence, Enterprise Technology, Digital Transformation, Future of Work, XR, and Extended Reality Type: Startup Activities: it services Technologies: IoT Synthetic Biology VR | 96 | 0 | 96 | 9 | |
APOLO Biotech Developing RNA's technologies Development of RNA-based technologies to enhance the productivity of crops (mainly intensive) which are respectful towards the environment and human health. Our OGM-free technology allows us to immunize crops against specific pathogens (fungi, insects, viruses), as a sort of "vaccine". In addition, we know how to modulate crop development, its response to the environment or the accumulation of metabolites of interest by designing RNAs as exogenous bioactive molecules to modulate the activity of plant genes. Fruits, Biotech, RNA, ARN, Plants, Vegetables, and Crops Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 0 | 2 | 30 | |
BigHat Biosciences BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases. BigHat is backed by Section 32, Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids … Type: Startup Activities: biotech deeptech it services Technologies: A.I. Synthetic Biology SaaS Generative A.I. | 19 | 0 | 19 | 107 | |
Paige Bridging Vision & Precision Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options. Learn … Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology A.I. - Machine Learning A.I. - Deep Learning Generative A.I. | 10 | 1 | 6 | 98 | |
Enveda Biosciences Engineering New Drugs from Nature At Enveda, we are systematically translating molecules found in medicinal plants into new drugs for challenging diseases. Our platform harnesses nature's complexity with the help of cutting-edge advancements in knowledge graphs, machine learning, and metabolomics. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I. - Machine Learning A.I. | 4 | 0 | 4 | 248 | |
Generate:Biomedicines Pioneering generative biology to create breakthrough therapeutics. Pioneering generative biology to create breakthrough therapeutics. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I. - Machine Learning A.I. Generative A.I. | 13 | 0 | 12 | 319 | |
Ranomics Ranomics offers innovative solutions for protein engineering, drug discovery, genomics research and synthetic biology Ranomics offers high throughput solutions for protein engineering, drug discovery, genomics research and synthetic biology. Using our VariantFind and VERG genomics platforms, Ranomics offers partners the a scalable solution to engineer and screen genetic variants in a wide range of model organisms. Our industry leading DNA Variant libraries and high-throughput cell assays help researchers to hit their research objectives faster and with better results than traditional methods. Over the years, we have worked with top biotech and pharma companies in the US and worldwide. Our partners … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 5 | |
Theranica A new era in migraine therapy Theranica is a neuromodulation therapeutics company dedicated to creating effective, safe, affordable, and low-side-effect therapies for idiopathic pain conditions. Our initial focus is on migraine, one of the most common neurologic disorders affecting over 1 billion people, with a high prevalence and morbidity, especially among adolescents and females. The company’s award-winning flagship Nerivio® REN wearable is changing the game for migraine sufferers, especially the 100 million adolescents facing this complex and non-curable disease. Nerivio is the first and only REN wearable that harnesses the natural power of the brain to shut off migraine symptoms … Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 3 | 0 | 2 | 72 | |
TolerogenixX GmbH The Smart Way to Immune Tolerance TolerogenixX vision is to innovate Immunosuppression with its newly developed MIC Cell Treatments. MIC Cell Treatment is a curative ATMP approach to achieve a sustained regulation of the immune system in Transplant - and Autoimmune Disease Patients. TolerogenixX has been able to generate strong pre-clinical as well as clinical data in the indications of Transplantation and Autoimmune Diseases e.g. SLE since its foundation in 2016. Type: Startup Activities: biotech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 5 | |
Stemcentrx, Inc. Founded in 2008, Stemcentrx combines state-of-the-art research and GMP manufacturing capabilities. This has allowed us to advance from target discovery in our laboratory to treating patients in clinical trials at an accelerated pace. We are investigating many of the largest and most lethal cancers through our proprietary platforms that identify cancer stem cells, discover novel targets, engineer and manufacture antibodies and antibody drug conjugates. Our mission is to develop therapies that cure and significantly improve survival for cancer patients. We are pioneering new approaches to eliminate cancer stem cells, which initiate and perpetuate tumors. Stemcentrx has assembled a talented and … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 7 | |
Halo Join a community of scientific experts working together to bring new innovations to the world Halo is a partnering platform that helps corporate R&D teams discover new technologies, build relationships with the researchers and startups behind them, and more efficiently scale external partnerships globally through the power of networks and AI. Since launching in January 2020, more than 7,000 universities from 135+ countries have joined the platform. In 2021, Halo was recognized as one of Fast Company's 2021 World Changing Ideas. On Halo, corporate R&D divisions post areas of interest for research collaborations (ie. Request-For-Proposals) and interested parties (scientists, startups, … Type: Startup Activities: biotech deeptech fintech Technologies: Synthetic Biology | 11 | 1 | 10 | 162 | |
Aratana Therapeutics Inc. Aratana Therapeutics is a wholly owned subsidiary of Elanco Animal Health. Aratana Therapeutics, Inc. (Nasdaq: PETX) is a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats. Our mission is to successfully develop and deliver best-in-class therapeutics, provide comprehensive service to veterinarians and serve as a collaborator of choice for human and animal health companies. We believe our therapeutics are highly differentiated, resolve recognizable needs in compelling markets and have therapeutic profiles superior to the standard of care. Our FDA-approved and commercially available therapeutics include: - A prostaglandin receptor antagonist that specifically targets … Type: Startup Activities: deeptech pettech biotech manufacturing Technologies: Synthetic Biology | 2 | 0 | 0 | 16 | |
NeurologyLive Neurology Live is your trusted news source for breaking drug approvals, pipeline trials and emerging trends in neurology. The digital and print publication provides physicians and other healthcare professionals with up-to-date disease-specific news, clinical information and other resources that can help them provide better care to patients. At Neurology Live, you'll find in-depth conference coverage and information about upcoming meetings, content from our affiliated print journals, video interviews with leading physician experts and other multimedia resources. Get all the latest news on individual medical conditions in our condition centers: • Dementia & Alzheimer Disease • Epilepsy • Headache & Migraine … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 6 | 0 | 5 | 1 | |
Bionic Power Inc. Stand Taller. Walk Stronger.TM The AgilikTM is a smart, powered orthotic designed to improve gait for numerous conditions. Bionic Power’s purpose is to design and develop lower-body smart orthoses that improve quality of life by enhancing personal mobility and walking abilities. Stand Taller, Walk StrongerTM The AgilikTM smart orthosis helps patients retain or increase their independence and mobility. This is especially critical in children with knee-extension-deficiency disorders (typically from Cerebral Palsy, Spina Bifida, etc.) whose strength and endurance often deteriorate as they get older. The AgilikTM functions by assisting or resisting knee extension and flexion throughout the gait cycle. Approximately … Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology Robotics | 2 | 0 | 1 | 24 | |
PANPHARMA [Automatic translation follows] A leading specialist in injectables A responsible and committed laboratory, our ambition is to be an independent European leader in the field of essential medicines. Our mission for 40 years: acting together, every day, to guarantee patients reliable access to essential medicines. We develop, produce and market generic injectable medicines for hospitals and clinics in France and in more than 75 countries on 5 continents. Through three production sites in France and Germany, we specialize in the fields of generic injectable antibiotics, anesthetics and analgesics. As a responsible laboratory, with a long-term vision, we have decided to … Type: SMB Activities: deeptech Technologies: Synthetic Biology | 2 | 1 | 1 | 458 | |
Carers in Hertfordshire We aim to ensure that all carers in Hertfordshire are recognised and valued; are informed and supported in their caring. Carers in Hertfordshire is concerned first and foremost to support unpaid carers, whatever the caring circumstances or the condition of the person receiving care. We support anyone who is caring, unpaid, for a family member or friend who is ill, elderly, disabled or has a physical or mental illness or who misuses drugs or alcohol. We aim to ensure that all carers in Hertfordshire are recognised and valued; are informed and supported in their caring role; have an opportunity for … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 4 | 0 | 4 | 58 | |
MDC Associates, Inc. Helping IVD innovators with RA/QA, FDA/CE submissions, CRO services, training, go-to and on-market support, and more. For more than 30 years MDC has helped innovators and entrepreneurs bring In Vitro Diagnostics (IVD) and Medical Devices to market that impact the lives of millions of patients around the world, every year. We support diagnostic makers and innovators by applying our expertise in Regulatory and Clinical Affairs, Quality Systems, and Data Management to help launch new advances that promote and protect the health of our global and local communities. regulatory, diagnostics, point of care, FDA, IVDR, quality systems, CRO, clinical trials, IVD, … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 44 | |
Greiner Bio-One International making a difference Greiner Bio-One specialises in the development, production and distribution of high-quality plastic laboratory products. The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries. Greiner Bio-One has specialised in two business division, Preanalytics and BioScience. The Preanalytics business division, with headquarters in Kremsmünster (Austria), develops and produces innovative collection systems for human and veterinary blood, urine and saliva samples, with the aim of making day-to-day, routine tasks in hospitals, laboratories and doctors’ practices easier and safer. This division also covers customised software solutions (Greiner eHealth Technologies) which ensure … Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 2 | 0 | 0 | 542 | |
Certest Biotec, S.L. Products and solutions for Raw Materials, Diagnostics and Pharma. MORE THAN DIAGNOSTICS! Highly specialized and customer-oriented, Certest Biotec consists of four divisions, including Raw Materials, Immunodiagnostics (Rapid Tests, Turbidimetry, and CLIA), Molecular Biology under the VIASURE brand, and Pharma. Certest Raw Materials provides high quality solutions for developing and manufacturing your IVD assays. Our expertise in protein expresión & purification, monoclonal antibodies develoment & manufacturing and primers & probes manufacturing offer to our customers a priceless support in their challenging proyects. Certest Immunodiagnostic -Rapid Test, Turbidimetry, CLIA- is committed to providing a comprehensive portfolio of diagnostic reagents for detecting infectious … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 216 | |
Biomedal Bioinnovation at your service. Biomedal S.L is a biotechnology company whose mission is to develop and commercialize new technologies, services and products for research, bioindustry and diagnostics. The company develops its activities in two areas: Biomedal Life Sciences and Biomedal Diagnostics. Biomedal Life Science is devoted to the development and commercialization of products and services for life sciences research, and technology for industrial bioprocesses. Its own technology allowed the improvement of recombinant protein production.Biomedal Life Science also functions as a CRO (Contract Research Organization) and provides services and support to pharmaceutical or biotechnology companies. Biomedal Diagnostics offers a large variety … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 29 | |
Ingenza Ltd ADVANCED BY NATURE. ADVANCED BY NATURE® Ingenza is a dynamic CRDMO whose understanding of nature and unique engineering biology toolbox, accelerate the customer journey through key milestones to commercial success. We engineer biological systems to make everything from therapeutics to enzymes and consumer products, addressing challenges in human health and the global environment. Enzyme Discovery, Enzyme Evolution, Molecular Biology, Protein Synthesis, High Throughput Screening, Strain Engineering, Fermentation, Process Development, and Synthetic Chemistry Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 0 | 3 | 45 | |
Owen Mumford Innovation in healthcare solutions. We are an industry leader in the medical device market with a diverse product range including advanced automatic injection devices for drug delivery and innovative blood sampling products including lancets, lancing devices and safety lancets. Established in 1952 by Ivan Owen and John Mumford, we have 70 years of experience with offices, manufacturing sites and distributors located around the globe. Our corporate headquarters are located in Woodstock, Oxford UK. We are dedicated to providing innovative healthcare solutions for the management of a variety of medical conditions. With one of the most advanced global research, design and … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 3 | 0 | 3 | 420 | |
BPGbio, Inc. #AI #biopharma #therapeutics #mitochondrial #proteinhomeostasis #oncology #neurology #raredisease #drugdiscovery BPGbio is a leading biology-first AI-powered clinical stage biopharma focused on mitochondrial biology and protein homeostasis. The company has a deep pipeline of AI-developed therapeutics spanning oncology, rare disease and neurology, including several in late-stage clinical trials. BPGbio’s novel approach is underpinned by NAi, its proprietary Interrogative Biology Platform, protected by over 400 US and international patents; one of the world’s largest clinically annotated non-governmental biobanks with longitudinal samples; and exclusive access to the most powerful supercomputer in the world. With these tools, BPGbio is redefining how patient biology can be … Type: SMB Activities: biotech deeptech Technologies: A.I. Data Analytics Synthetic Biology | 11 | 2 | 7 | 71 | |
Zeta Farmaceutici Group [Automatic translation follows] Pharmaceuticals and cosmetics: two great Italian traditions. We renew them every day. Zeta Farmaceutici Group is an Italian industrial company formed by a group of companies specialized in the development, production and distribution of drugs, medical devices, cosmetics, food supplements, biocides. 1. Production and marketing of products with its own brands. Our brands are present in 10,000 pharmacies and parapharmacies, with widespread distribution throughout Italy. 2. Contract manufacturing. Industrial partnership with national and international companies and groups. Our brands. Euphidra. Make up, dermoscomesi, hair coloring, personal hygiene. Amido Mio. The rice starch line to cleanse and protect … Type: SMB Activities: cosmetics deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 151 | |
Excelya Expertly delivering clinical trials operations, with care. Excelya is an independent partner that serves Biotech, Pharma, and Medical Device organizations with a comprehensive range of Full-service CRO, FSP, and Resourcing solutions guided by compassion, care, and excellence. Founded in 2014 and headquartered in Paris, France, and operating in 28 countries across Europe, USA and India, Excelya has a global team of 900+ experts who understand the critical needs of clients to provide bespoke and robust trial solutions across a broad spectrum of therapeutic areas, with speciality focus on Oncology & Hematology, Rare Disease & Pediatrics, Infectious Disease, Inflammation & Immunotherapy, … Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 8 | 2 | 3 | 717 | |
Genomic Vision Genomic Vision is a French biotech providing tools and services to visualize and characterize single DNA molecules. GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology. GENOMIC VISION initial focus is towards early cancer detection and … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 0 | 19 | |
Advamedica Inc. Biomaterials. Hemostats. Medtech Advamedica Inc. is a deep science medtech company focused on biomaterial based medical devices. Hemostats, Woundcare, and Biomaterials Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 3 | |
Zyrcular Foods [Automatic translation follows] Development, production and distribution of plant-based protein. Development, production and distribution of alternative protein foods. We want to be part of the food movement that will improve the world we live in today and tomorrow. Distributor of plant-based protein products, Plant-based producer, and Alternative protein producer Type: Startup Activities: agritech deeptech foodtech Technologies: Synthetic Biology | 2 | 0 | 2 | 14 | |
Ortho-tag Ortho-tag is pioneering a new frontier in healthcare. Ortho-tag develops technologies that enable and enhance wireless in-body communication, data exchange/storage, and nanodiagnostic functionality of medical implants - providing a versatile, in-vivo platform that connects digital health applications and implanted biosensors with the human body. In-Body Communication • A unique system in which to wirelessly communicate with implanted medical devices through the human body, utilizing proprietary transcutaneous volume conduction • Volume conduction communications offers many advantages over traditional RFID, as well as enabling the highest level of data security • Powering implantable chips/tags and nanobiosensors without the use of an internal … Type: Startup Activities: deeptech healthtech Technologies: A.I. Batteries Sensors Synthetic Biology Wireless | 0 | 0 | 0 | 7 | |
Cocoon Biotech Cocoon Biotech, Inc., was founded in 2013 to bring the freedom of living a healthy productive life to patients worldwide. Cocoon Biotech is developing a drug-delivery platform based on formulations of fibroin, a protein derived from the cocoon of the silkworm (Bombyx mori). Recent advances in our understanding of fibroin biochemistry has allowed expansion of the versatility of the material into alternate physical formats such as hydrogels and implants loaded with active drug substances. Cocoon is leveraging silk fibroin as a novel biomaterial for the stability and delivery of therapeutics across human health and animal health. Cocoon’s first products are … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 6 | |
Biosortia, Inc. Unlocking the Hidden Chemistry of Microbiomes for Next-Generation Therapeutics with ISMM + HiMo-silco Generative AI Biosortia Pharmaceuticals is pioneering a revolutionary approach in drug discovery through its Industrial Scale Microbiome Mining (ISMM) technology. By accessing the vast, untapped chemical diversity found within natural microbiomes, We unlock a hidden world of small molecules that play crucial roles in cellular signaling and disease processes. These small molecules, often referred to as the "drug-like dark matter" of cellular biology, have been largely inaccessible until now. Our technology allows for the large-scale harvesting and exploration of these compounds, providing an unprecedented opportunity to discover … Type: Startup Activities: deeptech biotech Technologies: A.I. - Machine Learning A.I. Data Analytics Synthetic Biology | 1 | 0 | 1 | 10 |